MS-27-275 - MS 275 - MS-275 - MS 27-275 - SNDX-275 - entinostat
versus endocrine therapy alone
No demonstrated result for efficacy
entinostat 5 mg once per week + exemestane 25 mg daily (n=64)
vs.
exemestane plus placebo (n=66)
Sample size: 64/66
Primary endpoint:
FU duration: